888-969-2592
Kalkine 0
countryflagCA

Aurora Cannabis Inc

Healthcare CA ACB

6.065CAD
-0.145(2.33%)

Last update at 2025-07-07T16:42:00Z

Day Range

6.046.25
LowHigh

52 Week Range

4.959.90
LowHigh

Fundamentals

  • Previous Close 6.21
  • Market Cap307.67M
  • Volume272879
  • P/E Ratio18.23
  • Dividend Yield-%
  • EBITDA30.66M
  • Revenue TTM343.29M
  • Revenue Per Share TTM6.26
  • Gross Profit TTM 187.61M
  • Diluted EPS TTM0.30

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2024-03-31 2023-06-30 2023-03-31 2022-06-30 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2024-03-31 2023-06-30 2023-03-31 2022-06-30 2022-03-31
Income before tax -59.59900M -221.53200M -264.54867M -1720.12000M -1720.12000M
Minority interest - - 2.06M 0.35M 0.35M
Net income -69.32600M -198.99700M -263.78601M -1717.97900M -1717.62400M
Selling general administrative 104.94M 133.40M 68.22M 126.97M 126.97M
Selling and marketing expenses 51.94M - 51.97M 62.02M 62.02M
Gross profit 131.46M -33.35400M -60.44518M 21.23M 21.23M
Reconciled depreciation 33.07M - 65.23M 93.66M 93.66M
Ebit -12.59700M - -245.49672M -219.37500M -236.74900M
Ebitda 20.47M - -203.31683M -143.08900M -143.08900M
Depreciation and amortization 33.07M - 42.18M 76.29M 93.66M
Non operating income net other - - - - -
Operating income -46.45300M -220.67800M -245.49672M -219.37500M -231.44900M
Other operating expenses 297.36M - 477.08M 440.71M 440.71M
Interest expense 14.19M - 39.46M 71.81M 71.81M
Tax provision -0.55400M -15.23700M -15.23700M -2.14100M -2.14100M
Interest income 12.81M 2.53M 2.53M 4.51M 4.51M
Net interest income -1.37300M - -51.52500M -67.30600M -67.30600M
Extraordinary items - - - 0.00000M 0.00000M
Non recurring - - - - -
Other items - - - - -
Income tax expense -0.55400M - -20.24528M -2.14100M -2.14100M
Total revenue 270.28M 174.97M 231.58M 221.34M 221.34M
Total operating expenses 158.54M - 185.05M 240.60M 240.60M
Cost of revenue 138.82M 208.32M 292.03M 200.11M 200.11M
Total other income expense net -31.14700M - -19.05195M -1500.74500M -1433.43900M
Discontinued operations - - - - -
Net income from continuing ops -59.04500M - -1750.02200M -1717.97900M -1717.97900M
Net income applicable to common shares - -198.99700M -198.99700M -1717.62400M -1717.62400M
Preferred stock and other adjustments - - - - -
Breakdown 2025-03-31 2024-03-31 2023-06-30 2023-03-31 2022-06-30
Type yearly yearly yearly yearly yearly
Date 2025-03-31 2024-03-31 2023-06-30 2023-03-31 2022-06-30
Total assets 852.67M 838.67M 926.32M 926.32M 1084.36M
Intangible assets 45.16M 40.85M 59.68M 61.40M 70.70M
Earning assets - - - - -
Other current assets 10.66M 9.40M 66.54M 8.92M 119.01M
Total liab 244.07M 236.80M 440.25M 404.62M 422.00M
Total stockholder equity 567.17M 559.77M 486.08M 490.64M 661.84M
Deferred long term liab - - - - -
Other current liab - 45.39M - 66.50M 94.52M
Common stock - 6971.42M 6841.23M 6841.23M 6754.63M
Capital stock 6991.15M 6971.42M - - 6754.63M
Retained earnings -6367.74500M -6367.93600M -6056.41200M -6292.26500M -6038.27500M
Other liab - - - - 40.29M
Good will 43.87M 43.18M 18.71M 18.71M 0.00000M
Other assets - - 38.53M 38.53M 33.87M
Cash 137.92M 113.44M - 300.84M 437.81M
Cash and equivalents - - 234.94M 234.94M 437.81M
Total current liabilities 110.86M 124.62M 242.31M 237.74M 145.23M
Current deferred revenue - 1.69M - 1.74M 3.85M
Net debt - -8.64800M - -73.32000M -168.31600M
Short term debt - 57.22M 0.00000M 147.56M 33.00M
Short long term debt 21.51M 52.36M - - 26.85M
Short long term debt total - 104.79M - 227.52M 269.49M
Other stockholder equity - - -298.74600M -0.00000M -54.50800M
Property plant equipment - - 322.97M 322.97M 230.30M
Total current assets 478.33M 426.61M 479.93M 479.93M 745.12M
Long term investments - - - - 1.21M
Net tangible assets - - - - 587.99M
Short term investments 0.55M 4.04M 0.00000M 0.00000M 1.33M
Net receivables 35.02M 45.41M 35.02M 41.34M 47.05M
Long term debt 40.19M 4.90M 36.16M 36.16M 199.65M
Inventory 239.09M 186.38M 128.82M 128.82M 139.93M
Accounts payable 27.62M 20.32M - 21.94M 13.86M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -43.70700M - -58.32500M -54.50800M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 7.72M 12.03M - 14.06M 33.87M
Deferred long term asset charges - - - - -
Non current assets total 374.34M 412.07M - 446.39M 339.24M
Capital lease obligations 42.88M 47.53M - - 42.99M
Long term debt total - - 79.97M 79.97M 236.49M
Breakdown 2024-03-31 2023-06-30 2023-03-31 2022-06-30 2022-03-31
Type yearly yearly yearly yearly yearly
Date 2024-03-31 2023-06-30 2023-03-31 2022-06-30 2022-03-31
Investments -5.48700M - -54.67400M -36.60000M -36.60000M
Change to liabilities - - - 3.31M 3.31M
Total cashflows from investing activities - -27.29100M -27.29100M -36.60000M -36.60000M
Net borrowings - - - -170.83100M -170.83100M
Total cash from financing activities -47.92300M -71.40600M -56.47800M 147.78M 147.78M
Change to operating activities - - - 6.47M 6.47M
Net income -59.04500M -206.29500M -234.57275M -1717.97900M -1717.97900M
Change in cash -121.50300M -202.86500M -140.00900M 16.35M 16.35M
Begin period cash flow 234.94M 437.81M 440.85M 421.46M 421.46M
End period cash flow 113.44M - 300.84M 437.81M 437.81M
Total cash from operating activities -68.50800M -115.82100M -115.80500M -109.83800M -109.83800M
Issuance of capital stock 37.93M - 417.75M 350.19M 350.19M
Depreciation 33.07M 31.99M 42.18M 93.66M 93.66M
Other cashflows from investing activities - -15.15900M -15.15900M -0.18500M -0.18500M
Dividends paid - - - - -
Change to inventory 3.62M - 49.51M 21.07M 21.07M
Change to account receivables -4.33300M - 2.97M 18.76M 18.76M
Sale purchase of stock - 73.19M 73.19M 350.19M 350.19M
Other cashflows from financing activities -0.08900M -14.92800M -0.12300M -31.57800M -31.57800M
Change to netincome - - - 1464.18M 1464.18M
Capital expenditures 16.96M 12.13M 9.33M 32.21M 32.21M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -15.62700M -25.11600M -24.83600M 49.95M 49.95M
Stock based compensation 12.72M - 16.89M 13.76M 13.76M
Other non cash items -70.84100M - 159.74M 1452.97M 1452.97M
Free cash flow -85.46400M - -125.13200M -142.05100M -142.05100M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
ACB
Aurora Cannabis Inc		 -0.145 2.33% 6.07 18.23 90.91 0.90 0.54 0.80 5.33
BHC
Bausch Health Companies Inc		 0.11 1.17% 9.50 - 1.69 0.32 18.74 2.33 8.07
CRON
Cronos Group Inc		 0.06 1.99% 2.81 13.68 - 8.04 0.67 0.02 -1.9458
CURA
Curaleaf Holdings Inc.		 -0.02 1.71% 1.15 - 138.89 0.62 0.72 1.00 5.90
GUD
Knight Therapeutics Inc.		 -0.02 0.33% 6.03 60.30 80.65 1.61 0.76 1.27 6.84

Reports Covered

Stock Research & News

View All

Profile

Aurora Cannabis Inc., together with its subsidiaries, engages in production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers medical and consumer cannabis products; sale of medical and consumer use cannabis products; and the propagation of vegetables and floral plants. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.

Aurora Cannabis Inc

90B Street SW, Edmonton, AB, Canada, T6X 1V8

Key Executives

Name Title Year Born
Mr. Miguel Martin CEO & Director 1972
Mr. Glen Ibbott Chief Financial Officer NA
Mr. Alex Miller Exec. VP of Operations & Supply Chain NA
Ms. Lori Schick Exec. VP of HR NA
Mr. Andre Jerome Exec. VP of Global Bus. Devel. NA
Ananth Krishnan VP of Capital Markets & Investor Relations NA
Mr. Nathalie Clark Exec. VP, Gen. Counsel & Corp. Sec. NA
Michelle Lefler VP of Communications & PR NA
Mr. Carey Squires Exec. VP of Corp. Devel. & Strategy NA
Mr. John Barnet Chief Cultivator NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.